Feasibility and utility of dual-energy chest CTA for preoperative planning in pediatric pulmonary artery reconstruction.
Evan J ZuckerAya KinoHeiko SchmiedeskampVirginia HinostrozaDominik FleischmannFrandics P ChanPublished in: The international journal of cardiovascular imaging (2019)
The purpose of this study was to assess in pediatric pulmonary artery (PA) reconstruction candidates the feasibility and added utility of preoperative chest computed tomography angiography (CTA) using dual-energy technique, from which perfused blood volume (PBV)/iodine maps can be generated as a surrogate of pulmonary perfusion. Pediatric PA reconstruction patients were prospectively recruited for a new dose-neutral dual-energy CTA protocol. For each case, the severity of anatomic PA obstruction was graded by two pediatric cardiovascular radiologists in consensus using a modified Qanadli index. PBV maps were qualitatively reviewed and auto-segmented using Siemens syngo.via software. Associations between Qanadli scores and PBV were assessed with Spearman correlation (r) and ROC analysis. Effective radiation doses were estimated from dose-length product and ICRP 103 k-factors, using cubic Hermite spline interpolation. 19 patients were recruited with mean (SD) age of 6.0 (5.1), 11 (57.9%) female, 11 (73.7%) anesthetized. Higher QS correlated with lower PBV, both on a whole lung (r = - 0.54, p < 0.001) and lobar (r = - 0.50, p < 0.001) basis. The lung with lowest absolute PBV was predictive of the lung with highest Qanadli score, with AUC of 0.70 (95% CI 0.47-0.93). Qualitatively, PBV maps were heterogeneous, corresponding to multifocal PA stenoses, with decreased iodine content in areas of most severe obstruction. In conclusion, dual-energy chest CTA is feasible for pediatric PA reconstruction candidates. PBV maps show deficits in regions of more severe anatomic obstruction and may serve as a novel biomarker in this population.
Keyphrases
- dual energy
- pulmonary artery
- computed tomography
- image quality
- coronary artery
- pulmonary hypertension
- end stage renal disease
- contrast enhanced
- pulmonary arterial hypertension
- ejection fraction
- chronic kidney disease
- newly diagnosed
- randomized controlled trial
- prognostic factors
- magnetic resonance imaging
- patients undergoing
- early onset
- traumatic brain injury
- peritoneal dialysis
- radiation therapy
- clinical practice
- patient reported outcomes
- artificial intelligence
- deep learning